Thu, April 7, 2022
Wed, April 6, 2022
Tue, April 5, 2022
Mon, April 4, 2022
Sun, April 3, 2022
Fri, April 1, 2022
Thu, March 31, 2022
Wed, March 30, 2022

Anupam Rama Maintained (APLS) at Buy with Increased Target to $69 on, Apr 4th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-increased-target-to-69-on-apr-4th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Anupam Rama of JP Morgan, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Buy with Increased Target from $66 to $69 on, Apr 4th, 2022.

Anupam has made no other calls on APLS in the last 4 months.



There are 4 other peers that have a rating on APLS. Out of the 4 peers that are also analyzing APLS, 0 agree with Anupam's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Anupam


  • Madhu Kumar of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $86 on, Monday, March 7th, 2022
  • Timur Ivannikov of "Raymond James" Maintained at Strong Buy with Increased Target to $114 on, Tuesday, March 1st, 2022
  • Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Decreased Target to $112 on, Tuesday, January 11th, 2022
  • Derek Archila of "Wells Fargo" Initiated at Buy and Held Target at $84 on, Wednesday, December 8th, 2021

Publication Contributing Sources